Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.4, 2008-04, pp. : 453-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Brimonidine 0.2%/Timolol 0.5% Ophthalmic Solution: In Glaucoma and Ocular Hypertension

By Frampton James E.

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 753-761

Adis International

Access to resources Recommend Favorite

Ketorolac 0.45% Ophthalmic Solution

By McCormack Paul L.

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 583-589

Adis International

Access to resources Recommend Favorite

SLI 381 appears suitable for once-daily dosing in paediatric patients with attention-deficit hyperactivity disorder

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Moxifloxacin 0.5% Ophthalmic Solution: In Bacterial Conjunctivitis

By Keating Gillian M.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

In Situ Ophthalmic Gel of Ciprofloxacin Hydrochloride for Once a Day Sustained Delivery

By Jain Satishkumar Shah Sejal Rajadhyaksha Namita Pirthi Pal Singh P. Amin Purnima

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 4, 2008-04 ,pp. : 445-452

Informa Healthcare

Access to resources Recommend Favorite